Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virbac
Carros, Provence-Alpes-Côte d'Azur, Francecorporate.virbac.com ↗
- Ownership
- Public · VIRP
- Employees
- ~5500
- Development stage
- Other
01
Overview
Virbac is one of the world’s largest independent animal health companies. It develops, manufactures, and markets a comprehensive portfolio of vaccines, pharmaceuticals, parasiticides, dermatology products, dental care items, nutritional supplements and diagnostic tools for both companion animals and livestock. The company has recently expanded into novel modalities such as therapeutic antibodies through partnerships like MabGenesis. Its commercial footprint spans over100 countries with strong R&D capabilities across five continents. In recent years it has launched innovative solutions including an antimicrobial-free treatment for canine otitis externa in Asia and URSOLYX™ Soft Chews targeting skeletal muscle mRNA expression in dogs via collaboration with Emmyon Inc.
- Therapeutic areas
- OtherDermatologyInfectious Diseases
- Modalities
- Vaccines (biologicals)Small molecules (antibiotics, anti-inflammatories)Therapeutic antibodiesNutritional supplementsParasiticidesDental products
- Industry
- Veterinary
02
Partnerships
MabGenesis Inc.: Licensing agreement for therapeutic antibodies targeting canine diseasesEmmyon Inc.: Collaboration on skeletal muscle biology leading to launch of URSOLYX™ Soft Chews
03
Financials
- Market cap
- $3.3B
- Total revenue
- $1.6B
- Enterprise value
- $3.5B
Beyond the preview
Go deeper on Virbac.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Virbac.